EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of Hepatitis C related membranoproliferative glomerulonephritis with combination of Interferon Alpha and Ribavirin A case report



Treatment of Hepatitis C related membranoproliferative glomerulonephritis with combination of Interferon Alpha and Ribavirin A case report



Journal of the American Society of Nephrology 10(PROGRAM AND ABSTR ISSUE): 98A, Sept




(PDF 0-2 workdays service: $29.90)

Accession: 035980494

Download citation: RISBibTeXText



Related references

Interferon-alpha in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis. American Journal of Kidney Diseases 38(6): E35-E35, 2001

Interferon alpha and ribavirin for membranoproliferative glomerulonephritis and hepatitis C infection. American Journal of Medicine 113(6): 516-519, 2002

Therapy with interferon-alpha plus ribavirin for membranoproliferative glomerulonephritis induced by hepatitis C virus. Brazilian Journal of Infectious Diseases 7(5): 353-357, 2003

Role of ribavirin in membranoproliferative glomerulonephritis associated with hepatitis C virus infection refractory to alpha-interferon. Nephron 92(2): 459-462, 2002

Alpha-interferon therapy in chronic hepatitis B virus infection with membranoproliferative glomerulonephritis A case report. Hepatology 18(4 PART 2): 233A, 1993

Leukocyte interferon-alpha and ribavirin in combination vs recombinant interferon alpha-2b and ribavirin combination for treatment of naive patients with chronic hepatitis C A multicenter Italian study. Hepatology 34(4 Pt 2): 593A, October, 2001

Re-treatment virologic response in chronic hepatitis C virologic non-responders and responder-relapsers to interferon monotherapy IFN alpha-2b induction followed by combination ribavirin/interferon alpha-2b vs combination ribavirin/interferon alpha-2b. Gastroenterology 120(5 Supplement 1): A 568, April, 2001

Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype. Journal of Gastroenterology and Hepatology 28(3): 443-449, 2013

Combination treatment with consensus-interferon and Ribavirin for chronic hepatitis C patients with Non-Response/Relapse to previous treatment with Alpha-Interferon and Ribavirin. Hepatology 36(4 Part 2): 363A, October, 2002

Successful treatment of hepatitis B virus -associated membranoproliferative glomerulonephritis with alpha interferon. Nephrology Dialysis Transplantation 14(5): 1272-1275, 1999

A case of cryoglobulinemic membranoproliferative glomerulonephritis associated with chronic hepatitis C which was effectively treated by interferon alpha-2b. Nihon Shokakibyo Gakkai Zasshi 98(5): 564-568, 2001

Preliminary treatment results of liver transplant recipients with recurrent Hepatitis C Virus nonresponsive to interferon alpha2b and ribavirin using combination pegylated interferon alpha 2b with ribavirin. Hepatology 36(4 Part 2): 183A, October, 2002

Successful treatment of hepatitis B virus (HBV)-associated membranoproliferative glomerulonephritis (MPGN) with alpha interferon. Nephrology, Dialysis, Transplantation 14(5): 1272-1275, 1999

Combination therapy with ribavirin plus alpha interferon for the treatment of chronic hepatitis secondary to hepatitis C virus in patients who have failed treatment with alpha interferon. Gastroenterology 114(4 PART 2): A1281, April 15, 1998

Comparison of therapeutic results between combination therapy of peginterferon alpha-2a plus ribavirin and interferon alpha-2b plus ribavirin according to treatment duration in patients with chronic hepatitis C. Korean Journal of Hepatology 14(1): 46-57, 2008